ConductScience.org, home

Paper8101302

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection.

Pape JW and 4 others. Lancet, 1993. Cited by 409 papers, by iCite.

Cite this record

ConductScience Library. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Papers, record 8101302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8101302

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection.
PubMed
Journal
Lancet
PubMed
Year
1993
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
409
iCite
Relative citation ratio, by iCite
13.9
iCite
Revised in PubMed
2022-03-17
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pape JWJ W
2Jean SSS S
3Ho JLJ L
4Hafner AA
5Johnson WD JrW D

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS-Related Opportunistic InfectionsMajor topic
HIV SeropositivityMajor topic
IsoniazidMajor topic
Tuberculosis, PulmonaryMajor topic
Acquired Immunodeficiency Syndrome
Adult
Drug Therapy, Combination
Female
HIV Infections
Humans
Male
Middle Aged
Pyridoxine
Treatment Outcome

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R21AI 33877NIAID NIH HHSUnited StatesR21AI033877PubMed and NIHNIH RePORTER
R37 AI 22624NIAID NIH HHSUnited StatesR37AI022624PubMed and NIHNIH RePORTER
TW00018FIC NIH HHSUnited StatesPubMedPubMed

Download CSV of grants

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in8103158Tuberculosis and HIV infection.https://conductscience.org/library/papers/8103158PubMed
Comment in8103159Tuberculosis and HIV infection.https://conductscience.org/library/papers/8103159PubMed

Download CSV of comments and corrections

Cited by108

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 409 citations.

PMIDTitleJournalYearIn PapersSource
42373911Breaking barriers: Implementation of a tuberculosis preventive treatment protocol among newly eligible populations with promising results.Eur J Clin Microbiol Infect Dis2026https://conductscience.org/library/papers/42373911PubMed
41029364Between Process Gaps, Knowledge, and Patient Trust: Healthcare Workers' Insights on Implementing Tuberculosis Preventive Therapy for People with HIV in the Philippines and Indonesia.Implement Sci Commun2025https://conductscience.org/library/papers/41029364PubMed
39810035Electronic structure modulation of ultrathin PtRuMoCoNi high-entropy alloy nanowires for boosting peroxidase-like activity and sensitive colorimetric determination of isoniazid and hydrazine.Mikrochim Acta2025https://conductscience.org/library/papers/39810035PubMed
39345793People Living With HIV Have More Intact HIV DNA in Circulating CD4+ T Cells if They Have History of Pulmonary Tuberculosis.Pathog Immun2024https://conductscience.org/library/papers/39345793PubMed
37143101Efficacy and safety of different regimens in the treatment of patients with latent tuberculosis infection: a systematic review and network meta-analysis of randomized controlled trials.Arch Public Health2023https://conductscience.org/library/papers/37143101PubMed
35486953The Impact of Vitamin A Deficiency on Tuberculosis Progression.Clin Infect Dis2022https://conductscience.org/library/papers/35486953PubMed
35071602Analysis of the Research Hotspot of Drug Treatment of Tuberculosis: A Bibliometric Based on the Top 50 Cited Literatures.Biomed Res Int2022https://conductscience.org/library/papers/35071602PubMed
34903214Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis.BMC Med2021https://conductscience.org/library/papers/34903214PubMed
34520459Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.PLoS Med2021https://conductscience.org/library/papers/34520459PubMed
34308207Implementation of Isoniazid Preventive Therapy Among HIV-Infected Children at Health Facilities in Nairobi County, Kenya: A Cross-Sectional Study.East Afr Health Res J2019https://conductscience.org/library/papers/34308207PubMed
34255776
Impact of Isoniazid Preventive Therapy on Tuberculosis incidence among people living with HIV: A secondary data analysis using Inverse Probability Weighting of individuals attending HIV care and treatment clinics in Tanzania.
PLoS One2021https://conductscience.org/library/papers/34255776PubMed
32773999Implementation of Isoniazid Preventive Therapy among People Living with HIV in Northwestern Nigeria: Completion Rate and Predictive Factors.J Glob Infect Dis2020https://conductscience.org/library/papers/32773999PubMed
32417884Enhanced Human Immunodeficiency Virus-1 Replication in CD4+ T Cells Derived From Individuals With Latent Mycobacterium tuberculosis Infection.J Infect Dis2020https://conductscience.org/library/papers/32417884PubMed
32411454Does Isoniazid Preventive Therapy Provide Better Treatment Outcomes in HIV-Infected Individuals in Northern Ethiopia? A Retrospective Cohort Study.AIDS Res Treat2020https://conductscience.org/library/papers/32411454PubMed
32053584Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020.MMWR Recomm Rep2020https://conductscience.org/library/papers/32053584PubMed
31688742Factors Associated With Latent Tuberculosis Infection Treatment Failure Among Patients With Commercial Health Insurance-United States, 2005-2016.J Public Health Manag Pract2021https://conductscience.org/library/papers/31688742PubMed
31364692Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration.Am J Epidemiol2019https://conductscience.org/library/papers/31364692PubMed
30896131Fifty Years of Supporting Global Health Research at the NIH Fogarty International Center.Ann Glob Health2019https://conductscience.org/library/papers/30896131PubMed
30885144Epidemiology and outcome of HIV patients in Finland co-infected with tuberculosis 1998-2015.BMC Infect Dis2019https://conductscience.org/library/papers/30885144PubMed
29770360Biomarkers Associated with Death After Initiating Treatment for Tuberculosis and HIV in Patients with Very Low CD4 Cells.Pathog Immun2018https://conductscience.org/library/papers/29770360PubMed

See all 108 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8101302

GET https://conductscience.org/api/papers/v1/8101302/cited_by?page=2